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Abstract There is evidence to suggest that genetic factors
play an important role in the development of basal cell car-
cinomas (BCCs), and that skin neoplasms might be a sign
for a genetic predisposition to cancer. We investigated
whether the incidence of visceral and skin malignancies
among Wrst-degree relatives of BCC-patients was
increased. Postal questionnaires were sent to 249 BCC-
patients, who were divided into two groups (young = BCC
under the age of 51 years and older = BCC over the age of
50 years), and asked them about cancer in their Wrst-degree
relatives. The reported numbers of cancer among the rela-
tives were compared with the expected numbers based on
sex and age-speciWc population-based incidence rates. The
accuracy of the reported diagnoses was veriWed. A total of
157 BCC-patients reported 277 malignancies in 1,272 rela-
tives. The incidence of the following cancers was higher
than expected in relatives from young BCC-patients: bone
and soft tissue (O/E = 3.91; 95% CI: 1.43–8.66), skin (O/
E = 2.13; 95% CI: 1.30–3.29) and digestive tract (O/
E = 1.59; 95% CI: 1.10–2.23). In relatives of older BCC-
patients, only the incidence of digestive tract cancer was
higher than expected (O/E = 1.44; 95% CI: 1.08–1.89).
Diagnoses that were veriWed turned out to be accurate in
87% of the cases. This study suggests that the risk of cer-
tain cancers, particularly that of the digestive tract, in Wrst-
degree relatives of BCC-patients is increased. These Wnd-
ings may indicate a genetic predisposition to both skin and
visceral malignancies in this patient group.
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Introduction
Cutaneous malignancies are the most common type of can-
cer in the western world, with basal cell carcinomas
(BCCs) accounting for about 75% of all skin cancers. The
life-time risk for BCCs is about one in six [1]. Most BCCs
have a superWcial or nodular growth pattern and are classi-
Wed as “non-aggressive”, whereas only a minority of the
tumours is associated with a considerable chance of local
recurrence. Although mortality rates are low, BCCs may
grow per continuitatem and cause severe local destruction.
Metastasis occurs in less than 1% [19, 22].
It is clear that the incidence of BCCs is increasing [5,
13]. Although most BCCs occur in older persons, the inci-
dence in young patients is increasing disproportionately [3,
19]. BCCs occur most on sun-exposed areas of the body,
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chronic skin exposure to ultraviolet radiation is supposed to
be a crucial factor in the development of skin cancer [9,
22]. However, it is not likely that the increased incidence in
young persons over time is due to sun exposure alone. In a
study by Lear et al. [11], outdoor occupation turned out not
to be a risk factor, which implies that ultraviolet radiation
cannot be the only explanation for the increased incidence
of BCCs. Additionally, mutations in the hedgehog signal-
ling pathway can be identiWed in almost all BCCs but less
than 50% of these mutations have the typical UV signature
[1, 9, 19]. Genetic factors might play a role in skin carcino-
genesis as skin cancer among Wrst and second degree rela-
tives is associated with multiple BCCs [26]. A considerable
part of the young patients has multiple BCCs and it was
shown that DNA repair capacity in young BCC-patients
without associated abnormalities is decreased [14]. Earlier
studies reported on families with multiple BCCs without
associated anomalies in subsequent generations and on
patients with multiple unilateral BCCs [8].
It is known that skin disorders can form a Wrst mani-
festation of a genetic predisposition to cancer: for exam-
ple, patients with basal cell naevus syndrome (BCNS),
which is caused by a germ line mutation in the PTCH1-
gene, have multiple BCCs at a young age, palmoplantar
pits, bone abnormalities, odontogenic keratocysts and an
increased risk of medulloblastomas and neoplasms of the
ovaries [12]. Patients with DNA repair disorders also
have an increased risk of developing non-melanoma skin
cancer (NMSC): Muir Torre syndrome, a variant of the
Lynch syndrome, is deWned by the combined occurrence
of at least one sebaceous gland neoplasm and a visceral
malignancy. The sebaceous neoplasms in this syndrome
include adenomas, epitheliomas and carcinomas.
Besides, BCCs and keratoacanthomas can be found [4,
16, 24].
Patients who have BCC have an increased occurrence of
second primary tumours of head and neck, bladder, larynx,
lung and colon as well as non-Hodgkin’s lymphoma and
melanoma [11, 23, 27]. Besides, the incidence of second
primary cancers of head and neck, thyroid, lung, larynx,
bladder, colon, as well as cutaneous malignant melanoma,
non-Hodgkin’s lymphoma and leukemias are increased
after NMSC appearance. Furthermore, earlier studies found
that mortality from noncutaneous malignancies was 20–
30% greater when patients have had NMSC [18].
These data illustrate that skin disorders might function as
a signal for a genetic predisposition to cancer. However, lit-
tle is known about the cause and relevance of having BCCs
at a young age and no data is available with regard to BCCs
in relation to visceral (i.e. non-skin) malignancies. In this
exploratory study, we hypothesise that BCCs indicate a
genetic predisposition to cancer and investigated whether
the incidence of visceral malignancies in Wrst-degree rela-
tives of BCC-patients is increased.
Patients and methods
After approval of the ethics committee was obtained,
postal questionnaires were sent to BCC-patients who vis-
ited the outpatient clinic of the departments of Dermatol-
ogy or Plastic surgery of the Radboud University Nijmegen
Medical Centre between 1993 and 1998 (n = 340). All
patients who could be traced (n = 249) were asked to com-
plete the questionnaire. Patients who did not respond
within 5 weeks received a reminder. Subsequently, all
patients who did not Wll out the questionnaire completely
or did not respond were approached by telephone. Patients
were asked about site and year of their Wrst and subsequent
BCCs and total number of BCCs. Furthermore, we asked
year of birth and year of death of all their Wrst-degree rela-
tives (parents, children and siblings). We also asked for
each relative whether that relative had ever been diagnosed
with cancer, year of diagnosis and type of cancer. With
respect to the Wrst-degree relatives without cancer, we
asked to Wll out year of birth and, if applicable, year of
decease. BCC-patients were divided into two groups:
young patients who had their Wrst BCC under the age of
51 years and older patients who had their Wrst BCC over
the age of 50 years. The cut-oV point of 50 years to diVer-
entiate “young” and “old” BCC-patients is based on expert
opinion which rests on the age distribution of BCCs that
shows an increase from 50 years onwards and analogy with
other cancers. For example, in colorectal carcinoma the
cut-oV point of 50 years is used to determine whether this
cancer may be hereditary or not [25].
In order to determine the accuracy of the reported cancer
diagnoses among relatives, we sent 124 BCC-patients, who
reported cancer among their relatives, a letter and requested
them to contact their relatives and ask them to give consent
to conWrm the diagnosis in the database from The Nether-
lands Cancer Registry (NCR). Two weeks later the BCC-
patients received consent forms that they could send to their
relatives. Whenever a relative had deceased, his/her chil-
dren or wife/husband could give consent for conWrmation
of the diagnosis. When relatives did not respond within
2 weeks, we approached the BCC-patients by telephone
and asked them whether their relatives were willing to par-
ticipate. Reported diagnoses of cancer were compared with
data from the NCR. When the diagnosis from the NCR
diVered from the reported diagnosis, we approached the rel-
ative by telephone to discuss this inconsistency.
The observed numbers of cancer were compared with
the expected numbers based on the Dutch age and sex-spe-
ciWc population-based incidence rates (http://www.ikcnet.nl).123
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based cancer registry, reference values can be taken
eYciently from the registry and can be considered more
valid and stable than estimates taken from a speciWc
(smaller) control group. In order to compute the expected
numbers of a speciWc type of cancer, we calculated each
relative’s time at risk as the number of years from his/her
date of birth to the date of data collection, cancer diagnosis,
or death, whichever came Wrst. We then stratiWed the total
person-years at risk by sex and age (5-year categories). The
expected numbers were obtained by multiplying the per-
son-years at risk in each category by the age and sex-spe-
ciWc incidence rates for the type of cancer obtained from
the NCR in 2003. Finally, the observed/expected (O/E)
ratios with 95% conWdence intervals (CIs) were calculated.
The 95% CIs were calculated using the Mid-P exact test.
Results
Out of 249 questionnaires, 157 (63%) were completed and
returned. After one reminder and telephone contact, 92
questionnaires could not be included in the analysis,
because the patients refused to participate (n = 47), did not
Wll out the questionnaire completely (n = 19) or did not
return the questionnaire (n = 26). Table 1 presents the char-
acteristics of BCC-patients and their relatives.
The 157 BCC-patients had 1,272 Wrst-degree relatives;
263 of them had cancer. As some relatives had more than
one form of cancer, 277 malignancies were reported in
total. The O/E ratios for diVerent forms of cancer in rela-
tives are given in Table 2; categories are based on the NCR
(http://www.ikcnet.nl). Two forms of cancer could not be
classiWed in one of the categories (cancer of the peritoneum
and a carcinoid tumour), and were excluded from the site-
speciWc analysis. Tumours that were described as “cancer
in the belly” (n = 3) were classiWed as a tumour of the
digestive tract.
The following cancers were statistically signiWcant,
higher than expected in relatives of young BCC-patients:
bone and soft tissue, skin and digestive tract. For relatives
of older BCC-patients, this only applies for cancers of the
digestive tract. In relatives of both young and older BCC-
patients, cancer of the male genital tract was statistically
signiWcant less observed than was expected.
Twenty-six BCC-patients refused to approach their rela-
tives who had cancer. The remaining 98 BCC-patients had
193 relatives with cancer; 105 of them gave permission to
conWrm the diagnosis. As the registration of the NCR
started in 1989, conWrmation of the diagnosis was only pos-
sible when the relative was diagnosed as suVering from
cancer after 1988. For that reason, conWrmation was sought
in 47 cases. The diagnosis was accurate in 41 (87%) of
these cases. Three relatives had more than one malignancy:
skin and colon, skin and blood/lymph node and breast and
female genital tract. Diagnoses that were inaccurate and the
corresponding accurate diagnoses according to the NCR are
shown in Table 3.
Discussion
In this study, we investigated whether BCCs are associated
with the occurrence of other malignancies in the patient’s
family. In relatives from both young and old BCC-patients,
an increased incidence of cancer of the digestive tract was
observed. Remarkably, this increased incidence was
strongly inXuenced by relatives with cancer of the liver.
However, it is likely that most of these tumours are metas-
tases instead of primary cancer. The increased O/E ratio is
thus the result of misclassiWcation bias. The same goes for
cancer of bone and soft tissue and, to a lesser extent, the
central nervous system.
The incidence of cutaneous malignancies among rela-
tives of young BCC-patients was higher than expected.
This might indicate that Wrst-degree relatives have an
increased risk of skin malignancies. However, it is also pos-
sible that this high rate is due to recall bias by the patients,
which led to an overestimation of skin malignancies. Fur-
thermore, it might be possible that the incidence rates for
skin cancer of the NCR are not correct; the Comprehensive
Cancer Centre South (IKZ) is the only Dutch Cancer Centre
that registers BCCs which implicates that the incidence of
skin tumours according to the NCR might be an underesti-
mation. Besides, the high incidence of skin malignancies
among relatives of BCC-patients might be based on coinci-
dence. An earlier pilot study conWrmed the increased inci-
dence of cutaneous malignancies among relatives of young
patients with skin cancer; in this study, the incidence of
cancer in Wrst-degree relatives from patients with skin can-
cer under the age of 51 years (“young”), relatives from
Table 1 Characteristics of BCC-patients and their relatives
BCC basal cell carcinoma
Characteristics Patients with a 
Wrst BCC <51 years 
of age (n = 75)
Patients with a 
Wrst BCC >50 years 
of age (n = 82)
Mean age Wrst 
BCC (range)
41.1 (15–50) 62.5 (51–88)
Mean number of
BCCs (range)
4.7 (1–42) 5.1 (1–150)
Number of relatives 583 689
Mean age of 
relatives (range)
54.6 (0–96) 62.5 (0–98)123
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and patients with benign skin neoplasms were compared
with a control group (patients who were treated with laser
therapy for vascular skin disorders). It turned out that the
incidence of skin cancer in relatives of young patients with
skin cancer was higher than that in both relatives of the
control group and relatives of the young patients with
benign neoplasms and relatives of old patients with skin
cancer (unpublished data). Another theoretical explanation
for the high incidence of cutaneous malignancies among
relatives of young BCC-patients is surveillance bias. In
reality, it seems unlikely that a BCC is a reason for
increased screening or case Wnding of tumours of internal
organs in relatives of patients. Furthermore, the cancers
diagnosed among relatives are not necessarily diagnosed
after the BCC diagnosis in the proband. Alternatively, we
do not think that cancer diagnoses in relatives may have led
to screening or case Wnding of BCC in the proband.
The number of relatives who suVered from cancer of the
male genital tract was lower than expected in both groups.
Earlier studies already reported a decreased risk of prostate
cancer in skin cancer-patients. It has been hypothesised that
ultraviolet radiation protects against the development of
prostate cancer, by means of vitamin D3 synthesis, whereas
it increases the risk of skin cancer [6]. It is unknown
whether this association could be extrapolated to relatives
of BCC-patients.
It might be possible that BCC-patients misreported the
cancers in their relatives as the occurrence of cancer in fam-
ily members was based solely on the questionnaire [2]. For
example, metastasised cancers may have been reported
instead of the primary tumour, leading to over reporting of,
for instance, bone and liver cancer [21]. Although only a
minority of the reported cancer diagnoses could be con-
Wrmed, it turned out that 87% of the cancer diagnoses in
Wrst-degree relatives were accurately reported by the BCC-
patients. This Wts with previous investigations which
showed that family cancer histories for Wrst-degree rela-
tives are accurate for the most common types of cancer,
especially breast and colon cancer [15, 20, 28]. Unfortu-
Table 2 Types of cancer in Wrst-degree relatives of BCC-patients
CI conWdence interval, Obs observed, O/E observed/expected, BCC basal cell carcinoma
Type of cancer First-degree relatives of patients with 
a Wrst BCC <51 years of age (n = 583)
First-degree relatives of patients with 
a Wrst BCC >50 years of age (n = 689)
Obs 95% CI Obs 95% CI
O/E Lower Upper O/E Lower Upper
All tumours 111 1.17 0.96 1.40 166 1.02 0.87 1.18
Blood, lymph node 8 1.08 0.50 2.05 6 0.50 0.20 1.03
Breast 20 1.25 0.79 1.90 28 1.10 0.75 1.57
Bone and soft tissue 5 3.91 1.43 8.66 2 1.03 0.17 3.41
Central nervous system 2 1.20 0.20 3.96 6 2.36 0.96 4.91
Endocrine glands 2 2.90 0.49 9.58 2 1.96 0.33 6.48
Head and neck 3 0.89 0.23 2.41 4 0.71 0.22 1.71
Skin 18 2.13 1.30 3.29 18 1.26 0.77 1.95
Male genital tract 3 0.29 0.07 0.78 9 0.47 0.23 0.87
Trachea, lung and mesothelioma 12 0.96 0.52 1.64 25 1.13 0.75 1.64
Digestive tract 31 1.59 1.10 2.23 50 1.44 1.08 1.89
Colorectal 18 1.50 0.91 2.32 22 1.03 0.66 1.53
Stomach 2 0.77 0.13 2.54 5 1.07 0.39 2.37
Liver 4 9.52 3.03 22.97 11 15.28 8.03 26.55
Oesophagus 1 0.60 0.03 2.94 2 0.68 0.11 2.24
Pancreas 3 1.62 0.41 4.41 4 1.22 0.39 2.94
Urinary tract 2 0.37 0.06 1.23 5 0.52 0.19 1.15
Female genital tract 4 0.82 0.26 1.97 8 1.00 0.47 1.90
Table 3 Diagnoses that were 
inaccurately reported by BCC-
patients and the corresponding 
accurate diagnoses according to 
the NCR
Reported NCR
Pleura Breast
Lung Colon
Oesophagus Stomach
Cervix Colon
Breast Colon
Peritoneum Colon123
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of cancer that were most likely to be misreported, such as
cancer of the liver and bone and soft tissue.
This exploratory study suggests that the incidence of can-
cer, and in particular, cancer of the digestive tract, in relatives
of BCC-patients is signiWcantly increased. The association
between NMSC and malignancies of the digestive tract is
well known; earlier studies showed that the incidence of rare
sebaceous skin tumours and keratoacanthomas in Lynch syn-
drome patients is increased and patients with a combination
of one of these skin tumours and a Lynch syndrome-related
malignancy are classiWed as having Muir Torre syndrome [7,
10, 17]. However, little is known with respect to the associa-
tion between BCCs and visceral malignancies. The increased
incidence of cancer of the digestive tract in relatives of BCC-
patients that was found in this study requires further investi-
gation in order to prove a genetic predisposition to both skin
and visceral cancers in these families.
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